VSIR and acute myeloid leukemia: More importantly, PD-1H was highly expressed on CD34+ and CD33+ AML blasts in BM from AML patients, consistent with the IHC findings (Figure 1, A and C, Supplemental Figures 2 and 4, and Supplemental Tables 1 and 2).